BeOne Medicines (ONC) EPS (Basic) (2015 - 2026)
BeOne Medicines' (ONC) quarterly EPS (Basic) came in at $0.16 in Q1 2026, up 17151.81% year-on-year from N/an in Q1 2025, and up 236.04% on a QoQ basis from $0.05 in Q4 2025.
BeOne Medicines (ONC) EPS (Basic) (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has 12 years of EPS (Basic) data on file, last reported at $0.16 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 17151.81% year-over-year to $0.16 in Q1 2026; TTM through Mar 2026 was $0.36, a 226.0% increase from a year earlier, with the FY2025 full-year figure at $0.2, up 142.96% from the prior year.
- EPS (Basic) for Q1 2026 stood at $0.16, up from $0.05 in the prior quarter.
- Over the last five years, EPS (Basic) for ONC reached as high as $0.16 in Q3 2023 and fell as low as -$0.42 in Q2 2022.
- Historically, EPS (Basic) has averaged -$0.13 across 5 years, with a median of -$0.11 in 2024.
- Across the five-year window, EPS (Basic) tumbled 684.18% in 2022 and soared 17151.81% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$0.33 in 2022, then gained by 18.46% to -$0.27 in 2023, then jumped by 59.03% to -$0.11 in 2024, then soared by 142.27% to $0.05 in 2025, then jumped by 236.04% to $0.16 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were $0.16 in Q1 2026, $0.05 in Q4 2025, and $0.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 1.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.16 |
| Dec 31, 2025 | 0.05 |
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | 0.07 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.09 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.19 |
| Dec 31, 2023 | -0.27 |
| Sep 30, 2023 | 0.16 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | -0.33 |
| Sep 30, 2022 | -0.41 |
| Jun 30, 2022 | -0.42 |
| Mar 31, 2022 | -0.33 |
| Dec 31, 2021 | -0.49 |
| Sep 30, 2021 | -0.36 |
| Jun 30, 2021 | -0.40 |